<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">In recent years, an increasing number of publications have reported details of DBS treatment and outcomes in genetically characterized PD patients. We present a systematic review of this literature, summarize key insights and discuss the rationale for genetic screening as a clinical tool for patient selection to DBS in PD.</p>
